Cancer Prevention in Lynch Syndrome: Dendritic Cell Therapy

We are testing a new treatment using dendritic cells to help prevent cancer in people with Lynch Syndrome. This study aims to assess its safety and effectiveness in this high-risk group.

>2 yearsSafety phase (I)Internal MedicineOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Clinic De Barcelona
Gastroenterology
El Altet, Spain
Sponsor: Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.